Advice on third primary Covid-19 vaccine dose for people with severely weakened immunity

The Joint Committee on Vaccination and Immunisation (JCVI) has recommended that people with severely weakened immune systems should have a third vaccine dose as part of their primary Covid-19 vaccination schedule. Read more

Annual screening for ovarian cancer does not save lives, study finds

A large scale ovarian cancer screening trial - UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) – has not been able to demonstrate that annual screening saves lives. Read more

Two studies report secondary surgery can extend survival in recurrent ovarian cancer

The results of two research studies have shown that overall survival can be improved following secondary surgery for ovarian cancer. Read more

A new drug berzosertib shows promising results as it halts tumour growth

One patient, diagnosed with ovarian cancer, saw her tumours shrink after combination treatment with berzosertib and chemotherapy. Read more

Knowing personal ovarian cancer risk reduces worry

A study funded by Cancer Research UK and The Eve Appeal provided volunteers with a personalised risk estimate of developing ovarian cancer. The volunteers' ovarian cancer worry and general cancer risk perception decreased over six months. Read more

New blood test can detect 50 types of cancer, including ovarian cancer

A new blood test that can detect more than 50 types of cancer, including ovarian cancer, has been revealed by researchers in the latest study to offer hope for early detection. Read more

Research suggests DNA changes give off 'signals' up to decades before they grow to be malignant

Researchers discovered that genetic mutations which fuel the growth of tumours often occur years before the cancer is discovered. Read more

MRI tool that can diagnose difficult cases of ovarian cancer to be tested at 18 UK trusts

The new tool can identify cases of ovarian cancer which are difficult to diagnose using standard methods. Read more

Research suggests acupuncture can help with chemotherapy-induced peripheral neuropathy

Peripheral neuropathy is a common side effect of taxol chemotherapy, and a less common side effect of carboplatin, both used to treat ovarian cancer. Read more

Immune discovery 'may treat all cancer'

Researchers at Cardiff University have discovered a part of our immune system which could be used to treat all cancers, including ovarian cancer. Read more

Promising results for trial looking at olaparib in combination with bevacizumab as first line treatment

News from the ESMO (European Society for Medical Oncology) 2019 conference Read more

Promising trial of drug to treat low grade serous ovarian cancer

The randomised trial of a drug called trametinib – previously used to treat melanoma – was shown to have an increased response rate compared with standard treatments. Read more

Researchers develop early detection test for ovarian cancer

Researchers from Queen’s University Belfast have developed a test that may be able to detect ovarian cancer up to two years earlier than current approaches. Read more

New 'Trojan horse' cancer drug in development

The new drug can get inside tumour cells and has shown promise in patients with six different advanced, drug-resistant cancers. Read more

New AI test identifies women with ‘very high risk’ ovarian cancer

The test scans the shapes of tumour cells to pick out women with especially aggressive ovarian cancer, so treatment can be tailored to their needs. Read more

Immune cells cast DNA ‘webs’ that may help ovarian cancer spread

It is possible that preventing the webs from being formed could limit the spread and avoid the need for the omentum to be surgically removed Read more

Early research suggests weight loss drug could help treat advanced ovarian cancer

Weight loss drug Orlistat may help women with treatment-resistant ovarian cancer respond to chemotherapy again. Read more

Study suggests statin use may reduce risk of ovarian cancer

Women who started taking a statin at the age of 50 or older had a significantly lower risk of developing any type of ovarian cancer over the next decade than non-statin users. Read more

Lee Rowley MP leads Westminster Hall debate on the diagnosis and treatment of ovarian cancer

You can read the official record of the debate online. Read more

Olapirib maintenance therapy shows benefit for women with BRCA positive ovarian cancer

The results of the Phase III SOLO-1 trial have shown an increase in progression free survival for women with a BRCA mutation compared with a placebo. Read more

Research shows psychological support reduces fear of progression

Researchers assessed the effect of three 90-minute sessions of psychological support on depression, fear of progression and quality of life. Read more

Trial for the drug CT900 which targets ovarian cancer cells expanded into a larger trial

The drug could be suitable for women with ovarian cancer for whom chemotherapy has failed, and whose tumours have high levels of the alpha-folate receptor on the surface of cancer cells. Read more

New study suggests taking low dose aspirin may lower the risk of ovarian cancer

However there are risks associated with aspirin use and anyone considering using it should discuss with their doctor. Read more

New study investigates reasons behind varied responses to PARP inhibitors

A new study has been published, looking into why some patients respond to PARP inhibitors while others do not. Read more